Thymalin

Taimalini

Taimalini

Tali vave

We supply high-purity Thymalin peptide with stable biological activity and strict quality inspection. This specialized immunomodulatory peptide supports thymus function adjustment, available for biotech wholesale and custom laboratory research projects.

Taimalini(Taimalini) is a bioactive polypeptide secreted by thymus tissue; derived from extracts of that tissue itself.

SKU: 198890 Fakakalakalasi:
Vahevahe ho'o 'ofa

Taimalini(Thymulin) is a bioactive polypeptide secreted by taima tissue; derived from extracts of that tissue itself. It acts precisely and multi-targetedly to regulate and enhance various aspects of maluʻi fakaselula function within the body. It spontaneously stimulates T limfosaiti matu'otu'a, lymphokine fakatupu koloa, natural killer cell ngāue, and thereby strengthens vakai'i 'o e malu'i, defense, mo e ngaahi ngaue fakama'a ..

Clinically, it is indicated for treating different forms of immunodeficiency disorders – congenital being a prime example, as well as chemotherapy-induced T-cell dysfunction. Significant improvement in patients’ overall immune levels are observed, providing long term support. Reversing age-related thymic atrophy and the subsequent functional decline is also well documented; restoration of immune function is a direct result of this process. Elderly disease resistance can be bolstered through Thymalin use.

Taimalini, as a potent immunomodulatory peptide, holds core value in maintaining immune homeostasis and overall health.

Fakahokohoko

Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH

Fika CAS

79621-14-0

Fomula Molekula

C33H54N12O15

Mamafa Molekula

858.864

Research Of Thymalin

1.Treatment of Immunodeficiency

Various acquired and congenital immunodeficiencies are effectively managed by Thymalin. Direct action on T lymphocytes (the ‘core’ immune cells) is central to this effect.

Long-term chemotherapy patients show clear clinical improvement in all measurable immune parameters. Defense capabilities, and to a large extent quality of life, are enhanced.

2.Boosting Immunity in Aging Individuals

The thymus undergoes significant involution in aging individuals, leading to reduced thymic hormone secretion and consequently decreased T-cell output. Diminished resistance to various bacterial infections is a well-documented consequence.

As an exogenous thymic signaling agent, Thymalin mimics the natural thymic microenvironment. Stimulating residual epithelial cell activity, T-cell generation is promoted and a more diverse T-cell repertoire can be restored.

Enhancing immune function of the aging individual is the primary effect; notably the immunomodulatory aspects play a crucial role in counteracting some aging processes.

3.Kanisa Adjuvant Therapy

Thymalin serves as a valuable adjunct in comprehensive cancer treatment. Modulating multiple immune responses against cancer cells is its defining capability.

Bone marrow suppression from either radio- or chemotherapy is effectively mitigated, facilitating faster white blood cell recovery. CD8+ cytotoxic T cell activity and CD4+ function are enhanced, improving the overall immune response against tumors.

Inhibiting progression, recurrence, and metastasis, Thymalin can synergize with modern therapies – patient survival and quality of life are positively influenced.

In cancer treatment, prolonged chemotherapy compromises the patient’s immune function, increasing susceptibility to secondary illnesses. Improving the quality of life of cancer patients is a key benefit Thymalin provides.

4.Managing Infections

Acute and chronic infections are likewise treated effectively; enhancing pathogen clearance, shortening disease duration and accelerating self-healing of damaged tissue are all part of its therapeutic profile.

5.Poupou'i 'a e Fakalelei'i mo e Fakafo'ou 'o e Tisiu

Clinical practice has shown Thymalin to accelerate healing after surgery, burns, uesia kovi mei ha a'usia, ulcers, mo e ngaahi me'a pehē., improve healing quality, and reduce scarring.

Fakatonutonu hake 'o e cellular differentiation factors and growth pathways is implicated. This potent cellular regenerative capacity is demonstrated by Thymalin.

COA

HPLC

MS

(1) Kilisitova, Z. Ko S.; Kalinina, Ko au. KO AU.; Semeleva, S. P.; Ryabchikov, O. P. Development of Endocrine and Lymphocytopoietic Functions of the Thymus in Human Embryogenesis. Bulletin 'o e Paiolosia 'ahi'ahi mo e Faito'o 2000, 130 (10), 1001-1004. DOI: 10.1023/ha:1002882327810.

(2) Ngaahi fehokotaki'anga, N.; Kavinisoni, V.; Tiatolova, HA.; Petukhov, M.; Vladimirova, E.; Sukhareva, M.; Fa'itoka, HA. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. Int J Mol Saienisi 2023, 24 (17). DOI: 10.3390/ijms241713377 From NLM Medline.

(3) Ngaahi fehokotaki'anga, N. Ko S.; Poliakova, V. O.; Tolofimovi, HA. V.; Sevositianova, N. N.; Kvetnoi, Ko au. M. Influence of peptides from pineal gland on thymus function with aging. Fakalakalaka 'i he Gerontology . 2011, 1 (3), 240-243. DOI: 10.1134/s2079057011030076.

(4) Litvinenko, G. KO AU.; Shurlygina, HA. V.; Dergacheva, T. KO AU.; Mel’nikova, E. V.; Trufakin, V. HA. Chrono- and Immunocorrection of Inflammatory Disorders of Internal Reproductive Organs in Women of Reproductive Age. Pulu Exp Paiolosia Med 2015, 159 (1), 62-65. DOI: 10.1007/s10517-015-2890-0 From NLM Medline.

(5) Sukova, G. V.; Sikilialova, HA. KO AU.; Pāteneva, T. HA.; Seviseniko, HA. N.; Sakaliuta, F. M. Uesia 'o e Thymalin 'i he Tumor mo e Thymus 'i he malumalu 'o e ngaahi tu'unga 'o e faito'o fakatupu 'i he Vivo .. Pulu Exp Paiolosia Med 2018, 165 (1), 80-83. DOI: 10.1007/s10517-018-4104-z Mei he NLM Medline.

Fakahokohoko:

Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH

CAS:

79621-14-0

M.W:

858.864 g/mol

Api Kumi Whatsapp Ngaahi Sevesi Koloa